Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Radiology | Journal

Back to Journal Articles

Adverse Cardiac Events Rare With Normal Angiography

Last Updated: December 13, 2010.

 

Increasing coronary artery disease burden on angiography ups negative outcomes

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Adverse cardiovascular events among patients with normal findings on cardiac computed tomography angiography (CCTA) are uncommon, with the increasing burden of coronary artery disease on CCTA associated with a higher rate of revascularization, myocardial infarction, and death, according to a study published online Dec. 8 in the Journal of the American College of Cardiology.

MONDAY, Dec. 13 (HealthDay News) -- Adverse cardiovascular events among patients with normal findings on cardiac computed tomography angiography (CCTA) are uncommon, with the increasing burden of coronary artery disease (CAD) on CCTA associated with a higher rate of revascularization, myocardial infarction (MI), and death, according to a study published online Dec. 8 in the Journal of the American College of Cardiology.

In a systematic review and meta-analysis, Edward A. Hulten, M.D., M.P.H., of the Walter Reed Army Medical Center in Washington, D.C., and colleagues searched multiple databases for longitudinal studies of CCTA with at least three months' follow-up of symptomatic patients with suspected CAD reporting major adverse cardiovascular events (MACE), consisting of death, MI, and revascularization. They included 18 studies evaluating 9,592 patients with a median follow-up of 20 months.

The investigators found that the pooled annualized event rates for obstructive versus normal CCTA were 8.8 versus 0.17 percent per year for MACE and 3.2 versus 0.15 percent for death or MI. The investigators also found that the pooled negative likelihood ratio for MACE after normal CCTA findings was 0.008 and the positive likelihood ratio was 1.70, with a sensitivity of 0.99 and a specificity of 0.41. After stratifying by no CAD, nonobstructive CAD, or obstructive CAD, they found incrementally increasing adverse events.

"Adverse cardiovascular events among patients with normal CCTA findings are very rare and comparable to a baseline risk among healthy patients. Increasing burden of CAD on CCTA is associated with an increasing rate of revascularization, MI, and death," the authors write.

One author disclosed receiving moderate speaker honoraria from Novartis Pharmaceuticals.

Abstract
Full Text

Copyright © 2010 HealthDay. All rights reserved.


Previous: SABCS: Breast Cancer Variant May Predict Onset of Disease Next: Survival Not Improved With Dietary Phosphate Restriction

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.